Today I had the chance to speak at the Annual Meeting of the German Pharmaceutical Society in Freiburg about targeted protein degradation as a novel paradigm in antiviral therapy.
Today I had the chance to speak at the Annual Meeting of the German Pharmaceutical Society in Freiburg about targeted protein degradation as a novel paradigm in antiviral therapy.
Just dropped our new preprint on bioRxiv. I’m incredibly proud of this manuscript, which explores a novel application of PROTACs as antivirals. Many thanks to everyone who contributed to this exciting research!
Just dropped our new preprint on bioRxiv. I’m incredibly proud of this manuscript, which explores a novel application of PROTACs as antivirals. Many thanks to everyone who contributed to this exciting research!
In Deutschlands Hochsicherheitslaboren wird an hochpathogenen Viren wie dem Ebola Virus geforscht. In Marburg entsteht aktuell ein neuer Laborbau. Einen aktuellen Einblick in das Projekt geben @markuseickmann.bsky.social und @crnlsrhd.bsky.social:
In Deutschlands Hochsicherheitslaboren wird an hochpathogenen Viren wie dem Ebola Virus geforscht. In Marburg entsteht aktuell ein neuer Laborbau. Einen aktuellen Einblick in das Projekt geben @markuseickmann.bsky.social und @crnlsrhd.bsky.social:
Yesterday was a truly special day – I successfully defended my doctoral thesis at the Institute of Virology in Marburg! After years of education, hard work, research, and perseverance—combined with passion, joy, and, at times, tears and challenges—I am beyond grateful to have reached this milestone.
January 31, 2025 at 6:38 AM
Yesterday was a truly special day – I successfully defended my doctoral thesis at the Institute of Virology in Marburg! After years of education, hard work, research, and perseverance—combined with passion, joy, and, at times, tears and challenges—I am beyond grateful to have reached this milestone.